These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 23348690)
1. TACC3 promotes epithelial-mesenchymal transition (EMT) through the activation of PI3K/Akt and ERK signaling pathways. Ha GH; Park JS; Breuer EK Cancer Lett; 2013 May; 332(1):63-73. PubMed ID: 23348690 [TBL] [Abstract][Full Text] [Related]
2. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC). Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823 [TBL] [Abstract][Full Text] [Related]
3. Consumption of high-fat diet induces tumor progression and epithelial-mesenchymal transition of colorectal cancer in a mouse xenograft model. Tang FY; Pai MH; Chiang EP J Nutr Biochem; 2012 Oct; 23(10):1302-13. PubMed ID: 22221675 [TBL] [Abstract][Full Text] [Related]
4. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer. Lu W; Xu Z; Zhang M; Zuo Y Int J Clin Exp Pathol; 2014; 7(10):7286-96. PubMed ID: 25400827 [TBL] [Abstract][Full Text] [Related]
5. TACC3 is essential for EGF-mediated EMT in cervical cancer. Ha GH; Kim JL; Breuer EK PLoS One; 2013; 8(8):e70353. PubMed ID: 23936413 [TBL] [Abstract][Full Text] [Related]
6. Celecoxib inactivates epithelial-mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cells. Bocca C; Bozzo F; Cannito S; Parola M; Miglietta A Mol Carcinog; 2012 Oct; 51(10):783-95. PubMed ID: 21882253 [TBL] [Abstract][Full Text] [Related]
7. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Larue L; Bellacosa A Oncogene; 2005 Nov; 24(50):7443-54. PubMed ID: 16288291 [TBL] [Abstract][Full Text] [Related]
8. TACC3 Promotes Gastric Carcinogenesis by Promoting Epithelial-mesenchymal Transition Through the ERK/Akt/cyclin D1 Signaling Pathway. Akanda MR; Park JS; Noh MG; Ha GH; Park YS; Lee JH; Moon KS; Kim CK; Lee KH Anticancer Res; 2021 Jul; 41(7):3349-3361. PubMed ID: 34230131 [TBL] [Abstract][Full Text] [Related]
9. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition. Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149 [TBL] [Abstract][Full Text] [Related]
10. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells. Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913 [TBL] [Abstract][Full Text] [Related]
11. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion. Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741 [TBL] [Abstract][Full Text] [Related]
12. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line. Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997 [TBL] [Abstract][Full Text] [Related]
13. Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells. Uttamsingh S; Bao X; Nguyen KT; Bhanot M; Gong J; Chan JL; Liu F; Chu TT; Wang LH Oncogene; 2008 Apr; 27(18):2626-34. PubMed ID: 17982486 [TBL] [Abstract][Full Text] [Related]
14. cPLA2α activates PI3K/AKT and inhibits Smad2/3 during epithelial-mesenchymal transition of hepatocellular carcinoma cells. Fu H; He Y; Qi L; Chen L; Luo Y; Chen L; Li Y; Zhang N; Guo H Cancer Lett; 2017 Sep; 403():260-270. PubMed ID: 28649002 [TBL] [Abstract][Full Text] [Related]
15. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway. Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907 [TBL] [Abstract][Full Text] [Related]
16. N-cadherin promotes thyroid tumorigenesis through modulating major signaling pathways. Da C; Wu K; Yue C; Bai P; Wang R; Wang G; Zhao M; Lv Y; Hou P Oncotarget; 2017 Jan; 8(5):8131-8142. PubMed ID: 28042956 [TBL] [Abstract][Full Text] [Related]
17. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways. Bouchard V; Demers MJ; Thibodeau S; Laquerre V; Fujita N; Tsuruo T; Beaulieu JF; Gauthier R; Vézina A; Villeneuve L; Vachon PH J Cell Physiol; 2007 Sep; 212(3):717-28. PubMed ID: 17443665 [TBL] [Abstract][Full Text] [Related]
18. Discovery of 3-(2-aminoethyl)-5-(3-phenyl-propylidene)-thiazolidine-2,4-dione as a dual inhibitor of the Raf/MEK/ERK and the PI3K/Akt signaling pathways. Li Q; Wu J; Zheng H; Liu K; Guo TL; Liu Y; Eblen ST; Grant S; Zhang S Bioorg Med Chem Lett; 2010 Aug; 20(15):4526-30. PubMed ID: 20580230 [TBL] [Abstract][Full Text] [Related]
19. Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways. Yang L; Hou Y; Yuan J; Tang S; Zhang H; Zhu Q; Du YE; Zhou M; Wen S; Xu L; Tang X; Cui X; Liu M Oncotarget; 2015 Sep; 6(28):25755-69. PubMed ID: 26342198 [TBL] [Abstract][Full Text] [Related]
20. The hepatitis B virus X protein promotes pancreatic cancer through modulation of the PI3K/AKT signaling pathway. Chen Y; Bai X; Zhang Q; Wen L; Su W; Fu Q; Sun X; Lou Y; Yang J; Zhang J; Chen Q; Wang J; Liang T Cancer Lett; 2016 Sep; 380(1):98-105. PubMed ID: 27339327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]